On disclosed annual figures, sales rose from KRW 14.6 billion in 2022 to KRW 92.1 billion in 2023 (up 530.3%), KRW 127.6 billion in 2024 (up 38.5%), and KRW 170.1 billion in 2025 (up 33.4%). Sales grew for three consecutive years from 2023 through 2025, and 2025 was the largest year in the 2022 to 2025 period.
Operating results swung from an operating loss of KRW 8.61 billion in 2022 to operating profit of KRW 3.06 billion in 2023, a turnaround to profit. Operating profit then rose to KRW 6.22 billion in 2024 (up 103.1%) before falling 74.7% to KRW 1.57 billion in 2025.
The operating margin was -58.9% in 2022, 3.3% in 2023, 4.9% in 2024, and 0.9% in 2025. Net income attributable to controlling shareholders was KRW 3.93 billion in 2023, fell to KRW 1.11 billion in 2024, and turned into a net loss of KRW 9.79 billion in 2025.
Consolidated net loss including non-controlling interests was KRW 10.4 billion in 2025. Sales scale expanded, but margins weakened after 2024, and 2025 earnings measures moved into losses.
At the end of 2025, total liabilities were KRW 152.4 billion against total equity of KRW 81.5 billion, of which KRW 62 billion belonged to controlling shareholders. Operating cash flow moved from an inflow of KRW 4.81 billion in 2024 to an outflow of KRW 14.9 billion in 2025.
Quarterly sales rose from KRW 40.9 billion in Q3 2025 to KRW 74.9 billion in Q2 2026, then eased to KRW 68.4 billion in Q3 2026. Operating losses were KRW 664 million in Q1 2026, KRW 2.4 billion in Q2, and KRW 4.98 billion in Q3, three consecutive loss quarters with a widening loss.
Q1 2026 showed net income attributable to controlling shareholders of KRW 5.67 billion despite the operating loss, so non-operating items deserve review in the annual report. Controlling-shareholder net losses followed in Q2 and Q3 2026, and the last four quarters total a net loss of KRW 16.1 billion. The company attributed the operating loss mainly to higher R&D and marketing spending.